Introduction
Centrosomal protein 110 kDa, abbreviated CCP110, is a conserved eukaryotic protein that associates with centrioles and centrosomes during cell division. The gene encoding CCP110 is located on chromosome 7 in humans and has homologues in a broad range of metazoan species, including mammals, birds, fish, and insects. CCP110 plays a pivotal role in maintaining centriole integrity and ensuring accurate duplication of the centrosome, thereby contributing to the fidelity of mitosis and cytokinesis. Studies of CCP110 function have revealed its involvement in developmental processes and its potential association with certain human diseases, particularly microcephaly and cancers characterized by centrosome amplification.
Gene and Protein
Gene Structure and Chromosomal Location
The human CCP110 gene resides on chromosome 7q11.2 and spans approximately 20 kilobases. It contains nine exons that encode a single polypeptide chain of 1127 amino acids. Alternative splicing generates at least two transcript variants differing in the length of the N‑terminal region, yet both encode proteins that retain the conserved C‑terminal domain responsible for centrosomal targeting. Comparative genomic analyses show that the gene is syntenic across vertebrates, indicating strong evolutionary conservation of its sequence and regulatory elements.
Expression Patterns
RT‑PCR and in situ hybridization studies demonstrate that CCP110 mRNA is ubiquitously expressed in embryonic tissues, with higher levels detected in proliferative compartments such as the developing brain, gut epithelium, and testis. In adult tissues, expression is most pronounced in the testes, ovaries, and proliferative stem cell niches, including the intestinal crypts and hair follicle bulges. Quantitative proteomics confirm that the protein is enriched in cells undergoing active cell division, whereas differentiated, post‑mitotic cells display markedly reduced CCP110 levels.
Protein Structure and Domains
CCP110 is a 112.6 kDa protein comprising several distinct structural motifs. The N‑terminal half (residues 1–500) is largely disordered and contains a predicted cyclin‑binding domain that mediates interaction with cyclin‑dependent kinases (CDKs). The C‑terminal region (residues 501–1127) contains a leucine‑zipper–like coiled‑coil domain that mediates dimerization and association with the centrosomal scaffold protein CP110. Multiple predicted phosphorylation sites, predominantly within the serine‑rich stretches of the N‑terminal region, suggest regulatory control by mitotic kinases such as Polo‑like kinase 1 (PLK1) and Aurora A. The protein lacks canonical catalytic motifs, supporting its classification as a structural adaptor rather than an enzyme.
Subcellular Localization
Immunofluorescence microscopy reveals that CCP110 localizes to the proximal ends of centrioles, specifically to the distal portion of the parent centriole during late mitosis. The protein exhibits a biphasic localization pattern: it concentrates at the centriole during the G2 phase, then redistributes to the basal body during ciliogenesis in post‑mitotic cells. Loss of CCP110 leads to ectopic centrosome foci, indicating a critical role in centriole cohesion and segregation.
Function
Centriole Duplication and Disengagement
CCP110 is essential for the regulated duplication of centrioles. During late S and G2 phases, the protein localizes to the proximal end of the mother centriole and associates with CP110 to form a cap that suppresses premature centriole assembly. Depletion of CCP110, either by siRNA or CRISPR/Cas9-mediated knockout, results in over‑duplication of centrioles, yielding cells with more than the typical two centrosomes. This phenotype is attributed to the loss of the CP110 cap, which normally blocks pro‑centriole formation until the appropriate cell cycle stage.
Regulation of Mitotic Progression
In addition to its structural role, CCP110 modulates the activity of mitotic kinases. It directly binds to PLK1 through its N‑terminal cyclin‑binding domain, facilitating PLK1 recruitment to the centrosome. PLK1 phosphorylates CCP110 at multiple serine residues, triggering its dissociation from the centriole during the transition from prophase to metaphase. Failure of this dissociation leads to delayed centrosome separation and aberrant spindle assembly, which can induce chromosomal instability.
Centrosome-Mediated Signaling
CCP110 interacts with the pericentriolar material (PCM) component pericentrin, thereby influencing the recruitment of γ‑tubulin ring complexes (γTuRC) to the centrosome. This interaction is crucial for nucleating microtubules that form the spindle apparatus. Loss of CCP110 impairs γTuRC assembly, resulting in reduced microtubule nucleation capacity and defective spindle morphology.
Clinical Significance
Human Genetic Disorders
Genetic studies have identified de novo loss‑of‑function mutations in CCP110 in patients with microcephaly and related neurodevelopmental disorders. These mutations often affect the coiled‑coil domain, disrupting centrosomal localization. Patient-derived fibroblasts exhibit centrosome amplification and defective neuronal progenitor proliferation, providing a mechanistic link between CCP110 dysfunction and impaired brain development.
Oncogenic Potential
Aberrant expression of CCP110 has been observed in several tumor types, including glioblastoma, breast carcinoma, and colorectal cancer. In many cases, elevated CCP110 levels correlate with increased centrosome numbers, a hallmark of aneuploid cancers. Functional assays show that overexpression of CCP110 promotes chromosomal instability, enhancing tumor cell migration and invasion. Conversely, targeted suppression of CCP110 reduces tumor cell proliferation and sensitizes cells to mitotic poisons, suggesting a therapeutic avenue.
Model Organisms and Research
Zebrafish (Danio rerio)
Knockdown of ccp110 in zebrafish embryos using morpholino antisense oligonucleotides leads to delayed gastrulation, reduced brain size, and frequent microcephaly. The phenotype mirrors that seen in human patients, supporting the functional conservation of CCP110 across vertebrates. Live imaging of fluorescently tagged zebrafish CCP110 demonstrates centrosome dynamics similar to those observed in mammalian cells.
Mouse (Mus musculus)
Conditional knockout of Ccp110 in murine neural progenitors causes microcephaly and cortical layering defects. Conditional deletion in the adult mouse brain results in impaired neurogenesis and increased apoptosis of progenitor cells. These findings reinforce the essential role of CCP110 in neurodevelopment and maintenance of the adult brain’s regenerative capacity.
Drosophila melanogaster
The fly homologue of CCP110, known as Ccp110, has been studied primarily in the context of neuroblast division. Loss of function results in centriole amplification and asymmetric division defects. Genetic interaction screens identify Ccp110 as a modifier of Polo kinase activity, underscoring the evolutionary conservation of its regulatory pathways.
Cellular Localization and Dynamics
High‑resolution microscopy has mapped CCP110 to the distal segment of the mother centriole, overlapping with the CP110 cap. During early prophase, CCP110 dissociates from the centriole, coinciding with the onset of PCM maturation. In interphase, CCP110 is largely absent from the centrosome but accumulates at the basal body in ciliated cells, where it contributes to basal body docking and cilia formation. Quantitative fluorescence recovery after photobleaching (FRAP) experiments show that CCP110 exchanges slowly at the centriole, indicating stable association during critical cell cycle windows.
Protein Structure and Domains
Coiled‑Coil Domain
The C‑terminal coiled‑coil domain of CCP110 is necessary for dimerization and binding to CP110. Structural modeling predicts a parallel leucine‑zipper motif, supported by co‑immunoprecipitation assays that demonstrate direct interaction with CP110. Mutations within this domain abrogate centrosomal targeting and lead to cytoplasmic mislocalization.
Cyclin‑Binding Motif
Within the N‑terminal region, CCP110 harbors a conserved cyclin‑binding motif (RXLXXL). This motif mediates interaction with CDK2, facilitating phosphorylation by CDK2 during S phase. Phosphorylation at serine 247 within this motif modulates CCP110’s affinity for CP110, thereby controlling centriole engagement.
Serine‑Rich Phosphorylation Cluster
Serine residues 480–520 form a cluster that is heavily phosphorylated by PLK1 during mitosis. Phosphorylation induces conformational changes that release CCP110 from the centriole, permitting centriole disengagement. Mass spectrometry analysis of mitotic cells has identified 13 distinct phosphorylation sites across this cluster.
Interactions
CP110
CP110, a centriole‑associated protein, is the primary binding partner of CCP110. The interaction occurs via the coiled‑coil domains of both proteins. This complex forms a protective cap that prevents untimely pro‑centriole assembly. Genetic epistasis experiments indicate that CCP110 acts upstream of CP110 in regulating centriole duplication.
Polo‑Like Kinase 1 (PLK1)
PLK1 phosphorylates CCP110 at multiple residues, facilitating its dissociation from the centriole during mitotic entry. Co‑localization studies show that PLK1 accumulates at the centrosome immediately after CCP110 is displaced, suggesting a coordinated handover of regulatory control.
Pericentrin
Pericentrin, a scaffold protein of the PCM, interacts with CCP110 to recruit γ‑tubulin ring complexes. This interaction is essential for efficient microtubule nucleation. Co‑immunoprecipitation assays reveal a direct binding interface involving the N‑terminal region of CCP110 and the central domain of pericentrin.
γ‑tubulin
Through pericentrin, CCP110 indirectly associates with γ‑tubulin. Loss of CCP110 reduces the amount of γ‑tubulin at the centrosome, impairing microtubule nucleation. Rescue experiments with γ‑tubulin overexpression partially restore spindle assembly in CCP110‑deficient cells, confirming functional linkage.
Pathways
Centriole Duplication Cycle
The centriole duplication cycle involves licensing, assembly, and maturation. CCP110 functions primarily at the licensing step by forming a cap with CP110 that prevents early assembly of pro‑centrioles. Its removal is a prerequisite for the recruitment of SAS‑6 and other cartwheel components.
Mitotic Kinase Cascade
During G2, CDK2 phosphorylates CCP110, priming it for PLK1 action. PLK1 then phosphorylates additional sites, causing dissociation. This sequential phosphorylation cascade ensures that centriole disengagement aligns temporally with spindle formation.
Microtubule Nucleation Pathway
CCP110 influences the microtubule nucleation pathway by modulating the recruitment of γ‑tubulin to the centrosome via pericentrin. Proper nucleation is critical for spindle bipolarity and accurate chromosome segregation.
Regulation
Cell Cycle‑Dependent Regulation
CCP110 levels rise during S phase, peak in G2, and fall during early mitosis. Transcriptional regulation involves E2F transcription factors that activate CCP110 expression during the G1/S transition. Post‑translational regulation is mediated by CDK2 and PLK1 phosphorylation, which control its stability and centrosomal association.
Proteolytic Degradation
During late mitosis, ubiquitin‑mediated proteolysis targets CCP110 for degradation via the APC/C–Cdh1 complex. This degradation ensures that CCP110 is absent from the centrosome during the completion of mitosis and cytokinesis. Failure to degrade CCP110 results in persistent centrosome cap formation and defective spindle dynamics.
Feedback from Centrosomal Components
The presence of CP110 at the centriole provides negative feedback on CCP110 recruitment. CP110 overexpression enhances CCP110 cap stability, whereas CP110 depletion destabilizes the complex. This feedback loop maintains a balance between centriole engagement and disengagement.
Research Methods
Gene Knockdown and Knockout
- siRNA and shRNA mediated knockdown of CCP110 in cultured cell lines.
- CRISPR/Cas9 genome editing to generate complete gene knockouts or point mutations.
- Conditional knockout mouse models using Cre/loxP system.
Immunofluorescence and Live‑Cell Imaging
- Antibody staining for CCP110, CP110, pericentrin, and γ‑tubulin.
- Fluorescent protein tagging (GFP–CCP110) for real‑time observation.
- Super‑resolution microscopy (STED, SIM) to resolve centriole cap structure.
Biochemical Interaction Assays
- Co‑immunoprecipitation and pull‑down assays to map protein–protein interactions.
- Mass spectrometry to identify phosphorylation sites and binding partners.
- Yeast two‑hybrid screening to discover novel interactors.
Functional Assays
- Microtubule nucleation assays using immunostaining for acetylated α‑tubulin.
- Chromosome missegregation assays measuring micronuclei formation.
- Cell proliferation and viability assays under drug treatment conditions.
Transcriptomic and Proteomic Profiling
- RNA‑seq of patient-derived cells with CCP110 mutations.
- Proteomic profiling of centrosomes isolated from cells with altered CCP110 expression.
- Single‑cell RNA‑seq to assess heterogeneity in centrosome number across tissues.
See also
- Centrosome
- CP110
- Polo‑Like Kinase 1
- Microcephaly
- γ‑tubulin ring complex
No comments yet. Be the first to comment!